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uncertainty. Our data recommend daily kV CBCT imaging and 
setup corrections for this group of patients.  
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Purpose or Objective: To review CBCT images of 35 pts 
receiving radical irradiation for localized prostate cancer, 
according to an IGRT protocol based on the use of 
intraprostatic calcifications as natural fiducial markers for 
the evaluation of inter-fraction organ motion. 
 
Material and Methods: Between 2013 and 2014, 646 KVCBCT 
images of 35 pts radically irradiated with moderately 
hyopofractionated VMAT (2.5 Gy/fract.- 70 Gy in 28 fract.) 
for localized prostate cancer were acquired according to an 
IGRT protocol aimed at evaluating the role of intraprostatic 
calcifications as natural fiducial markers. All the evaluated 
pts presented at least 3 calcifications of >2 mm located 
inside or at the borders of the CTV and contoured on high 
resolution CT-simulation scans and on each CBCT (mean: 18 
CBCT/patient). In order to assess the internal stability of the 
calcifications the distances between them were measured for 
each patient on both CT-simulation scans and each CBCT, 
then mean ± SD of differences between distances was 
calculated. Distances between calcifications and the center 
of mass of CTV were also calculated in 21 patients by drawing 
CTV on 360 CBCT images, contoured by a same physician. The 
center of CTV mass spatial coordinates (X, Y, Z) was 
determined for each CTV and finally the distances between 
the center of the CTV and the center of each calcification 
were measured. Stability of calcifications in respect of CTV 
was assessed by calculating mean values ± SD of measured 
distances. 
 
Results: The mean value of differences in distances between 
calcifications was -0.04 mm ± 1.54 SD, with 95% of values 
contained inside 3 mm (μ ± 2SD). The mean value of 
differences in distances between calcifications and center of 
mass of CTV (Fig. 1) was -0.03 mm ± 1.55 SD, with 95% of 
values contained inside 3 mm (μ ± 2SD). 
 
 
 
Conclusion: Our results derived from the analysis of a large 
data set of CBCT images confirm that intraprostatic 
calcifications, when >2 mm and present at least Nr.=3, 
properly selected and contoured, can be used as very reliable 
natural fiducials, with potential reduction of iatrogenic risks 
and costs associated with the implantation of fiducial 
markers for prostate cancer IGRT.  
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Purpose or Objective: Bony anatomy is used to match anal 
cancer patients treated using volumetric modulated arc 
therapy (VMAT). Only extreme volume changes due to 
bladder, rectum or bowel filling are currently highlighted to 
the responsible clinician. This study aims to determine the 
impact that changes in bladder volume has on the dose to the 
small bowel over the course of the treatment by comparing 
the dose to volumes outlined on cone-beam CT (CBCT) to the 
initial planned dose statistics. A more representative value of 
accrued dose to the small bowel over the course of treatment 
can also be gained. 
 
Material and Methods: Ten patients who were treated with 
VMAT for anal cancer were selected for this study. Weekly 
cone beam CT images were acquired to monitor extreme 
changes in bladder and rectum filling. Patients were asked at 
both planning CT and treatment to have a comfortably full 
bladder. The bladder and small bowel (contained within the 
scan) were outlined on three CBCTs by one clinician; week 
one, mid treatment and final week. The bladder volumes 
were compared over the course of the treatment and the 
maximum small bowel dose, amount of small bowel receiving 
30Gy (V30Gy) and 40Gy (V40Gy) were recorded. 
 
Results: The results in Table 1 show the variation in bladder 
volume. The V40Gy bowel volume was plotted against the 
difference between the bladder volume at CBCT and the 
initial planning scan with the intercept for the linear trends 
set to the planning CT volume for each patient (see Fig. 1). A 
similar trend was found for the V30Gy measurement. There 
was less impact on maximum dose to small bowel with 
changing bladder size.  
 
Table 1 - Bladder Volumes 
Patient 1 2 3 4 5 6 7 8 9 10 
Planning CT 
bladder 
volumes 
[Range 
from 
CBCTs] 
(cm3) 
579 
[426-
618] 
196 
[75-
628] 
278 
[146-
225] 
140 
[57-
248] 
157 
[31-
70] 
170 
[80-
232] 
182 
[146-
215] 
247 
[65-
227] 
239 
[79-
154] 
161 
[81-
191] 
 
 
Conclusion: In eight cases a smaller bladder at CBCT resulted 
in a greater volume of small bowel receiving clinically 
relevant doses compared to the initial planning CT. There 
were two patients where the trend indicated that a larger 
bladder increased small bowel dose. Limitations of this study 
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include poor visibility of the small bowel on the CBCTs, 
smaller field of view meaning less volume and variation 
between initial planning clinician and clinician outlining 
CBCTs. CBCT is now widely used for adaptive planning 
techniques and in this case has provided evidence for 
implementing a stricter bladder filling protocol to improve 
the accuracy of bowel dose statistics at planning. 
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Purpose or Objective: We report the results of our 
investigation into whole brain radiotherapy using linear 
accelerator-based intensity-modulated radiation therapy and 
volumetric-modulated arc therapy in cancer patients with a 
high risk of metastasis to the brain. Concretely, we assessed 
the absorbed dose and the rate of adverse effects for several 
organs at risk according to the tilt of a patient’s head. 
 
Material and Methods: From data regarding patients who had 
previously received WBRT, we arbitrarily selected five cases 
where measurements were made with the patients’ heads 
tilted forward and five cases without such tilt. We set the 
entire brain as the planning target volume, and the 
hippocampi, the lenses, the eyes, and the cochleae as the 
main OAR, and formulated new plans for IMRT (coplanar, 
non-coplanar) and VMAT (coplanar, non-coplanar). Using the 
dose-volume histogram obtained from the treatment plans, 
we calculated and compared the effective uniform dose and 
normal tissue complication probability of the OAR. In order to 
compare the extent of hippocampal sparing, we also 
analyzed the mean and the maximum doses. 
 
 
Results: When a patient received coplanar IMRT with the 
head tilted forward, the EUD and NTCP values for the 
hippocampus decreased by 13% and 81%, and the mean dose 
and maximum dose decreased by 8% and 7%, respectively. 
When the patient received non-coplanar treatment, the 
hippocampal EUD and NTCP values decreased by 2% and 15%, 
and the mean dose and maximum dose decreased by 2% and 
4%, respectively. For coplanar VMAT treatment, the EUD 
values decreased by 20%, the NTCP values decreased by 92%, 
and the mean dose and the maximum dose decreased by 10% 
and 13%, respectively. For non-coplanar treatment as well, 
the EUD values decreased by 14%, the NTCP values decreased 
by 81%, and the mean dose and the maximum dose decreased 
by 14% and 10%. 
 
 
Conclusion: If the patient tilted the head forward when 
receiving the Linac-based treatment, for the same treatment 
effect in the PTV, we confirmed that a lower dose entered 
the OAR, such as the hippocampus, eye, lens, and cochlea. 
Also, the damage to the hippocampus was expected to be the 
least when receiving coplanar VMAT with the head tilted 
forward, and we showed that damage to OAR, including the 
hippocampus, was the least overall when the head was tilted 
forward. Accordingly, if patients tilt their heads forward 
when undergoing Linac-based WBRT, we anticipate that a 
smaller dose would be transmitted to the OAR, resulting in 
better quality of life following treatment. 
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Purpose or Objective: Postoperative radiotherapy (PORT) of 
tongue cancer is associated with side-effects such as acute 
mucositis. Our department previously used intraoral stents to 
depress the tongue to minimize the dose to the palate. 
However, the stents were not always very well tolerated and 
there were also reproducibility issues. Therefore, the 
intraoral stents were omitted. In order to still ensure target 
coverage, we have included the air gap (if present) above the 
tongue in the target volume (CTV tongue including the 
surgical bed) on the planning CT. We wanted to investigate 
whether the air gap is a systematic phenomenon over all 
treatment fractions, so that the size of the CTV could be 
reduced avoiding irradiating the palate. 
 
Material and Methods: We have so far included 10 patients 
with T1-T2 N0 M0 squamous cell carcinoma of the tongue 
referred to PORT. Nine patients were treated with 50 Gy in 2 
Gy fractions, and one patients with 60 Gy in 2 Gy fractions 
with concurrent chemotherapy (cisplatinum) because of 
positive surgical margins. All patients underwent daily kV 
cone-beam CT (CBCT). From each CBCT we obtained three 
distance measures from the sagittal images: The caudo-
cranial air gap from the cranial border of the tongue to the 
palate on the 1) lateral left, 2) midline and 3) lateral right 
side. 
 
Results: Two of 10 patients had air gaps between the tongue 
and palate systematically present over the treatment period 
(Figure, mean air gaps 6 mm and 8 mm) indicating that a 
caudo-cranial reduction of the CTV for these individuals could 
be safe. However, for the remaining 8 patients the tongue 
was mostly located cranially towards the palate. It was not 
possible to identify a relationship between the size of the air 
gap and clinical parameters such as resected volume, tumor 
size, infiltration depth, patient age or gender. 
 
 
 
